We show that DC/tumor activated with combined TLR2 and TLR4 are most effective inducer of MUC1-specific CTL activation compared with solitary TLR2- or TLR4-activated DC/tumor on a per fusion cell basis. The gene discussed is TLR4; the disease is neoplasm.